News Releases

Date	Title
11/27/2020	Genetron Health Provides Update on HCCscreen™ for Liver Cancer Early Screening in China
11/20/2020	COVID-19 Highlights Role of Early Detection in Fighting Threatening Diseases, Especially Cancer, Genetron CEO Tells CNBC Conference
11/19/2020	Genetron Health Named One of the “50 Smartest Companies in China 2020” by MIT Technology Review
11/12/2020	Genetron Health to Present at CNBC East Tech West Conference
11/9/2020	Genetron Health Reports Third Quarter 2020 Unaudited Financial Results and Provides Business Update
10/29/2020	Genetron Health to Present at Six Upcoming Investor and Industry Conferences
10/26/2020	Genetron Health to Announce Third Quarter Unaudited Financial Results and Host Investor Call on November 9, 2020
10/22/2020	Genetron Health Enters Exclusive Global Licensing Agreement with ImmuQuad Biotechnologies to Develop and Commercialize Minimal Residual Disease Assays in Hematologic Cancer
9/30/2020	Genetron Health Receives U.S. FDA Breakthrough Device Designation for its Blood-based NGS Test for Early Detection of Hepatocellular Carcinoma
9/25/2020	Genetron Health and CStone Pharmaceuticals Announce Launch of Clinical Trial in China for Companion Diagnostic Test in Development for Avapritinib
9/18/2020	Genetron Health to Highlight Data from 18 Studies at ESMO 2020
9/16/2020	Genetron Health and dMed Announce Partnership Agreement
9/8/2020	Genetron Health to Present at Upcoming Investor Conferences
8/29/2020	Genetron Health Joins Major R&D Project Led by the Ministry of Science and Technology in China for Early Screening of Lung and Digestive System Cancers
8/6/2020	Genetron Health Reports Second Quarter 2020 Unaudited Financial Results
7/29/2020	Genetron Health to Present at Canaccord Genuity 40th Annual Growth Conference
7/27/2020	Genetron Health to Announce Second Quarter Unaudited Financial Results and Host Investor Call on August 6, 2020
6/30/2020	Genetron Health Presents Cancer Clinical Research Data at AACR Virtual Annual Meeting Highlighting the Sensitivity and Specificity of its NGS Technology in Precision Oncology
6/19/2020	Genetron Health Announces Pricing of Initial Public Offering
6/11/2020	Genetron Health Strengthens Partnership with Thermo Fisher Scientific to Expand Precision Cancer Diagnosis and Monitoring Across China’s Public Hospitals
6/6/2020	Genetron Health Receives FDA Emergency Use Authorization for SARS-CoV-2 RNA Test and Approval for Export by Chinese Authority
5/20/2020	Genetron Health Announces Strategic Collaboration with DARUI on GENETRON S5 Platform
4/20/2020	Genetron Health Announces Forthcoming Unveiling of Its Cancer Research Papers at the AACR Annual Meeting
4/10/2020	Genetron Health Appoints Former FDA Senior Officer Dr. Yun-Fu Hu as Chief Medical Officer
4/7/2020	Genetron Health Announces Its Novel Coronavirus Nucleic Acid Detection Kit Is CE Marked and FDA-EUA Application Accepted, with Three Laboratories Passing NCCL’s COVID-19 EQA
3/20/2020	Genetron Health Contributes to China’s First Expert Consensus Statement on the Standardized Clinical Application of NGS Testing for Oncology
3/12/2020	Genetron Health Responds to Wuhan Huoshenshan Hospital's Request with Donation of NGS Platforms
2/21/2020	Genetron Health Announces Strategic Partnership with InnoCare on Biomarker-Driven Oncology Drug Development
2/13/2020	Genetron Health Announces NMPA Approval of its 8-gene Lung Cancer Assay and NGS Platform GENETRON S2000
1/30/2020	Genetron Health to Participate in China National Key Research and Development Project on Cancer Early Screening
1/14/2020	Genetron Health Announces Strategic Partnership with the National Brain Tumor Registry of China

News Releases

News Releases

News Releases

Search News